Osimertinib Mesylate Powder

Xi'an Sonwu Biotech Co., Ltd. is one of the most professional manufacturers and suppliers of osimertinib mesylate powder in China. We warmly welcome yuo to wholesale bulk osimertinib mesylate powder for sale here from our factory. Quality products and reasonable price are available.

What Type Of Drug Is Osimertinib
Osimertinib mesylate powder, also known as azd9291 mesylate powder, is the hydrochloride form of Osimertinib, an orally active, specific, irreversible epidermal growth factor receptor (EGFR) Tyrosine kinase inhibitor. It is a type of drug called a tyrosine kinase inhibitor (TKI). Specifically, it is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. Enzymes called tyrosine kinases are essential for cell signaling; blocking these enzymes could be a focused treatment strategy for some pathological cellular illnesses. Osimertinib treats non-small cell lung disease with specific mutations in the EGFR gene. These mutations, known as the EGFR-T790M mutations, are associated with resistance to other EGFR inhibitors. By inhibiting the activity of mutated EGFR, Osimertinib helps slow or stop the growth of diseased cells. It is mainly used to treat individuals with chronic myelogenous leukemia daily, particularly if the disease advances to the acute or regular phase. It may also play a role in the treatment of other blood disorders. If you have more questions about this product, please get in touch with Xi'an Sonwu. Xi'an Sonwu can provide you with azd9291 mesylate powder.

Certificate Of Analysis

Osimertinib Buy
Xi'an Sonwu Biotech Co. Ltd. has more than ten years of industry experience, specializing in producing and selling raw materials. Xi'an Sonwu has established solid and reliable partnerships with countries in America, Asia, Europe, and Oceania. Prioritizing product quality, Xi'an Sonwu works hard to satisfy each client's expectations in full by offering top-notch services.
Beginning with the careful selection of raw materials, every step of the production process for Xi'an Sonwu is subject to strict regulations. High-quality products are Xi'an Sonwu's top priority, and the company's dedication to perfection is seen in all aspects of its operations, including the selection of raw materials, manufacturing processes, sample testing, and staff professionalism. Xi'an Sonwu may reduce expenses without sacrificing quality by carefully monitoring every detail, guaranteeing that clients receive items of remarkable value.
Xi'an Sonwu is proud of the positive feedback it has received from customers, who have consistently recognized the quality of the products. To further prove product confidence, Xi'an Sonwu will provide samples for you to test.

Customers's Good Comment

Osimertinib Mesylate Drug Class
Osimertinib
Osimertinib mesylate powder and Osimertinib are often used interchangeably. Still, it is essential to note that Osimertinib usually refers to the active pharmaceutical ingredient (API), while azd9291 mesylate Tinib means the salt form of the drug. Essentially, Osimertinib is often used in scientific and clinical settings to refer to the active form of the drug. In contrast, it is the formulation containing the mesylate form of Osimertinib API, commonly used in drug development and dosage forms.

Gefitinib
Gefitinib and azd9291 mesylate are drugs used to treat NSCLC, but their chemical structures and mechanisms of action are different. For non-small cell lung disease with an EGFR mutation, gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, is commonly utilized as a first-line or adjuvant treatment. It is an irreversible inhibitor mainly used to treat EGFR T790M mutation-positive NSCLC, especially for patients who have previously received EGFR TKI treatment and developed resistance.

Erlotinib
Erlotinib is also a drug used to treat NSCLC. This product is an epidermal growth factor receptor tyrosine kinase inhibitor. It is mainly used to treat NSCLC patients with EGFR-activating mutations, especially those who have received Other patients who progress despite chemotherapy. Additionally, it is approved for the treatment of pancreatic disease. azd9291 mesylate is an EGFR inhibitor used to treat patients with particular EGFR gene mutations.

Afatinib
Afatinib can also be used to treat NSCLC, with several differences. First, their chemical structures and mechanisms of action are different. Afatinib is a selective tyrosine kinase inhibitor, targeting numerous epidermal growth factor receptors, including human epidermal growth factor receptor 4 (HER4). A more targeted EGFR inhibitor, mesylate is primarily used for non-small cell lung disease who have specific EGFR gene mutations, particularly those with T790M resistant mutations. Afatinib inhibits the tyrosine kinase activity on EGFR and HER2 receptors, hence blocking the growth signals of sick cells. It mainly blocks the growth signals of diseased cells by inhibiting the abnormal tyrosine kinase activity caused by the EGFR T790M mutation.

What Is The Use Of Osimertinib Mesylate
1. EGFR mutation-positive NSCLC
azd9291 mesylate is approved to treat NSCLC with EGFR-activating mutations. These mutations include exon 19 deletions or L858R substitution mutations.

2. EGFR T790M mutation
The medication is quite successful for individuals with NSCLC who have the EGFR T790M mutation. The T790M mutation is often associated with resistance to other EGFR tyrosine kinase inhibitors (TKIs).

3. First-line treatment
azd9291 mesylate may be used as a first-line treatment for NSCLC, especially for those patients with the abovementioned EGFR mutations.

4. Progressive cases previously treated with EGFR TKI
In addition, patients who have not responded well to previous EGFR TKI treatment may benefit from routine treatment with azd9291 mesylate.

What Is The Mechanism Of Action Of Osimertinib
The principle of action of Osimertinib Mesylate involves the specific inhibition of EGFR mutations. The receptor tyrosine kinase known as EGFR is essential for both the growth of diseased cells and regular cell function. The abnormal stimulation of normal cell signaling pathways resulting from the EGFR gene mutation can promote the unregulated growth and survival of ill cells. As the main target of azd9291, the T790M EGFR mutation is a frequent mutation among EGFR resistance mutations. It is an irreversible inhibitor that inhibits the autophosphorylation of EGFR by forming a covalent bond with the ATP binding site of EGFR and blocks further activation of the EGFR signaling pathway. As a result, diseased cells' proliferation and survival pathways are inhibited, leading to apoptosis and stasis of diseased cells. Compared with traditional EGFR inhibitors, azd9291 mesylate is more specific for the T790M mutation, making it a powerful tool for treating patients with EGFR mutation-positive NSCLC.
The main target of Osimertinib Mesylate is EGFR, especially EGFR with T790M resistance mutation. Tyrosine kinase receptor EGFR is found on the cell membrane. It initiates several signaling pathways that control cell development, proliferation, and survival. A small number of EGFR mutations can trigger aberrant signaling pathways, which aid in the growth and dissemination of sick cells. It binds explicitly and inhibits EGFR with T790M resistance mutation, thereby blocking abnormal signaling pathways, slowing the growth of diseased cells, and promoting their apoptosis.

Factory
1. Xi'an Sonwu Biotech Co., Ltd has a factory to produce, manufacture, and store the products, so it has adequate stock. Xi'an Sonwu has a well-ordered, clean, and tidy production department. Under Xi'an Sonwu, researchers can continuously develop high-quality new products.
2. Xi'an Sonwu has strict requirements on personnel allocation from production and testing to sales. To ensure that each product is escorted, rigorous data support and after-sales service are provided.

Certificate

Package

Logistics

Besides guaranteeing the product, the other most important thing is customers can receive the goods smoothly. So, Xi'an Sonwu supplies all kinds of couriers according to different needs.

FAQ
The following is general Osimertinib Mesylate dosage information:

First-line treatment: It is typically used as a first-line treatment for patients with EGFR T790M-positive non-small cell lung disease. In this case, the standard dose is 80 (mg) taken orally daily.

Second-line therapy: Patients who have progressed with their disease and have had prior EGFR tyrosine kinase inhibitors may also be treated with it. The dosage remains 80 mg orally daily.

If you want to know the azd9291 mesylate price, you can contact Xi'an Sonwu. Click the email, and then you get high-quality Osimertinib mesylate powder.
Email: sales@sonwu.com

Hot Tags: osimertinib mesylate powder, China, suppliers, manufacturers, factory, wholesale, buy, price, bulk, pure, raw, supply, for sale, Cetilistat Powder, Prostaglandin E1 Powder, Veliparib Hydrochloride Powder, Arecoline Hydrobromide Powder, Adenosine 5 Triphosphate Disodium Supplement, Spermidine HCL Powder